The use of both vaccines was abandoned several weeks ago over concerns about rare, but severe cases of blood clots in some recipients.
But the Danish authorities have had difficulty getting deliveries of the Moderna vaccine from the United States, forcing a revision of plans to have everyone vaccinated by September.
At the moment, the estimated delay amounts to two weeks.
Health Minister Magnus Heunicke told state broadcaster DR it was in this context that the government was asking the health authority to reconsider.
The authority withdrew AstraZeneca from the country’s vaccination programme in mid-April, and Johnson & Johnson in early May.
It cited not just the health concerns but the fact that the epidemic appeared to be under control and there seemed to be sufficient supplies of the approved vaccines, Pfizer/BioNtech and Moderna.
Denmark was the first European country to drop the two vaccines from its official campaign, but in May 20th it loosened the restrictions for anyone who was willing to take them.
- Explained: How does Denmark’s voluntary system work for AstraZeneca and Johnson & Johnson vaccines?
- Denmark allows AstraZeneca and Johnson & Johnson vaccines to be given by private suppliers
- Denmark pulls Johnson & Johnson jab from vaccination program
- Denmark withdraws AstraZeneca from Covid-19 vaccination programme